Mario C. Raviglione | |
---|---|
Born | |
Nationality | |
Alma mater | University of Turin |
Occupation(s) | Professor of Global Health, TB expert and former Director of the WHO Global TB Programme |
Years active | 1981–present |
Spouse | Angela Paraluppi Raviglione |
Mario C. B. Raviglione has been professor at the University of Milan, Italy since March 2018. He directs the activities focused on global health and aiming at pursuing didactic and research in this field as part of the new Multidisciplinary Research in Health Science (MACH) Centre . Part of his activities are devoted to teaching global health principles to undergraduate medical students, making the University of Milan the first in Italy, and one of the pioneers world-wide, introducing global health as a module among the required curricular courses. At the same university, Raviglione is now coordinating the first international Master Course in Global Health in Italy and one of the very few online worldwide . In 2019 and 2020, he was also Professeur Titulaire at the Global Studies Institute (GSI), Université de Genève, Suisse . Through the GSI, he has worked within the context of the Institute of Global Health . Previously, between 2003 and 2017, he was director of the Global Tuberculosis Programme at the World Health Organization (WHO) . He graduated in medicine from the University of Turin in 1980 and then trained in internal medicine and Infectious Diseases at Cabrini Medical Center in New York City and at Beth Israel Medical Center in Boston where he was a Harvard University Clinical Fellow in Medicine and specialised in AIDS. Back in Europe, Raviglione joined WHO in 1991 as a Junior Professional Officer, and spent a few years working on TB and AIDS, TB epidemiology in Europe, and anti-TB drug resistance surveillance and response. In the mid-1990s, he set up both the WHO global drug resistance surveillance project and the WHO global TB surveillance and monitoring systems . Among his major achievements are the contributions to the development of the WHO's DOTS Strategy in 1995, and the direction of the development of both the Stop TB Strategy in 2006 and the End TB Strategy in 2014 . During his years at WHO he worked with, and visited, more than 50 countries supporting their TB care, prevention, control and research activities. His research work has resulted in over 350 scientific articles and chapters on the topics of infectious diseases, HIV/AIDS, TB, and global health, including the TB chapters in the last eight editions of Harrison's Principles of Internal Medicine. He is editor of the 3rd and 4th (2006, 2009) edition of "Tuberculosis - A comprehensive international approach", a multi-author book, and associate editor of other books on public health, infectious diseases and tuberculosis. He directed the team that developed the book “Systematic screening for active tuberculosis – Principles and recommendations”, awarded by the British Medical Association as "Highly Commended Book" for Public Health in 2014 (https://www.bma.org.uk/-/.../about%20the%20bma/.../li-medicalbookawards-22-09-2...). He is among the top 10 most cited authors in the TB field. His h-index is 117 (Google Scholar) and 94 (Scinapse) and his work has been cited over 63000 times . He is also among the top 25 Italian epidemiological scientists and the top 100 Italian scientists in general . As an expert in TB, he has worked as a teacher or visiting professor at Johns Hopkins University, University of Geneva, University of Modena and Reggio Emilia, and University of Pavia.[ citation needed ] He has been visiting professor at the University of Brescia and has recently lectured at major universities including Harvard, McGill and Sydney. He participates in a variety of board of directors, scientific and advisory committees, including those of the TB Alliance, Doctors with Africa CUAMM, BE Health Association, International Health Commission of the Missionary Sisters of the Sacred Heart - Cabrini Ministries ,Fondazione 3Bi .[ citation needed ] and the McGill Global Health Programs International Advisory Board . In 2017-2018 and in 2023 he was member of the Lancet Commission on TB . During 2015-2017 he conceived and co-organised, with WHO and the Russian Federation Ministry of Health, the first Global WHO Ministerial Conference on TB in the Sustainable Development Era, held in Moscow on 16–17 November 2017, and his team worked towards ensuring that TB is raised in the international political agenda through the United Nations General Assembly high-level meeting on TB that was held in 2018 . As main Editor, he conceived and coordinated with other global health authorities the publication of a landmark book "Global Health Essentials" part of the Springer series devoted to the UN Sustainable Development Goals (SDGs) . This practical manual is a comprehensive book written by an esteemed international panel of over 150 experts from 70 institutions across 30 countries, and provides a succinct yet thorough exploration of key global health challenges, issues, and solutions.
In 2005, Raviglione received the Princess Chichibu TB Global Award for his achievements in TB control. In 2009 he was nominated Fellow of the Royal College of Physicians (F.R.C.P., London, UK). In 2010, he received the Wolfheze 20 Year Jubilee Award for his contributions to modern TB control practices in Europe. In 2014, he was appointed a Foundation Fellow of the European Respiratory Society (F.E.R.S.). In 2014, he received the Lifetime Achievement Award by the India International Public Health Conference of the Indian Medical Association. In 2016 he was made Honorary Member of the Russian Society of Phtisiatry and in 2017 he received the USAID Global Leader Award "in recognition of innovative approach, scientific rigor, and dedicated service in partnership to End TB" . In 2018 he received the "Sigillo Trecentesco" recognition from the City of Trieste for the global fight against tuberculosis and for his support to the response to an outbreak of TB among children in Trieste in 2016 . In November 2019 he received the title of honorary professor at the Centre for Immunobiology within the Blizard Institute, Queen Mary University of London, U.K.
Tuberculosis (TB), also known colloquially as the "white death", or historically as consumption, is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but it can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis. Around 10% of latent infections progress to active disease which, if left untreated, kill about half of those affected. Typical symptoms of active TB are chronic cough with blood-containing mucus, fever, night sweats, and weight loss. Infection of other organs can cause a wide range of symptoms.
James Jude Orbinski is a Canadian physician, humanitarian activist, author and leading scholar in global health. Orbinski was the 2016-17 Fulbright visiting professor at the University of California, Irvine, and as of September 1, 2017, he is professor and inaugural director of the Dahdaleh Institute of Global Health Research at York University in Toronto, Ontario, Canada. He was previously the CIGI Chair in Global Health Governance at the Balsillie School of International Affairs and Wilfrid Laurier University (2012-2017), Chair of Global Health at the Dalla Lana School of Public Health (2010-2012) and full professor at the Faculty of Medicine, University of Toronto (2003-2012), where he was the founding Saul Rae Fellow at Massey College. Orbinski's current research interests focus on the health impacts of climate change, medical humanitarianism, intervention strategies around emerging and re-emerging infectious diseases, and global health governance.
James (Jim) Chin is a public health epidemiologist. He works in public health surveillance and prevention of communicable diseases, particularly AIDS.
Tropical medicine is an interdisciplinary branch of medicine that deals with health issues that occur uniquely, are more widespread, or are more difficult to control in tropical and subtropical regions.
Jim Yong Kim, also known as Kim Yong (김용/金墉), is an American physician and anthropologist who served as the 12th president of the World Bank from 2012 to 2019.
Joia Stapleton Mukherjee is an associate professor with the Division of Global Health Equity at the Brigham and Women's Hospital and the Department of Global Health and Social Medicine at Harvard Medical School. Since 2000, she has served as the Chief Medical Officer of Partners In Health, an international medical non-profit founded by Paul Farmer, Ophelia Dahl, and Jim Kim. She trained in Infectious Disease, Internal Medicine, and Pediatrics at the Massachusetts General Hospital and has an MPH from Harvard School of Public Health. Dr. Mukherjee has been involved in health care access and human rights issues since 1989, and she consults for the World Health Organization on the treatment of HIV and MDR-TB in developing countries. Her scholarly work focuses on the human rights aspect of HIV treatment and on the implementation of complex health interventions in resource-poor settings.
Tuberculosis is a serious public health problem in China. China has the world's third largest cases of tuberculosis, but progress in tuberculosis control was slow during the 1990s. Detection of tuberculosis had stagnated at around 30% of the estimated total of new cases, and multidrug-resistant tuberculosis was a major problem. These signs of inadequate tuberculosis control can be linked to a malfunctioning health system. The spread of severe acute respiratory syndrome (SARS) in 2003, brought to light substantial weaknesses in the country's public health system. After the government realized the impact that the SARS outbreak had on the country, they increased leadership in their health department. After the SARS epidemic was brought under control, the government increased its commitment and leadership to tackle public health problems and, among other efforts, increased public health funding, revised laws that concerned the control of infectious diseases, implemented the world's largest internet-based disease reporting system to improve transparency, reach and speed, and started a program to rebuild local public health facilities and national infrastructure.
Seth Franklin Berkley is an American medical epidemiologist and a global advocate of the power of vaccines. He is the founder and former president and CEO of the International AIDS Vaccine Initiative (IAVI) and former CEO of Gavi, the Vaccine Alliance. He is currently a senior advisor to the Pandemic Center at Brown University School of Public Health.
Eric Goosby is an American public health official, currently serving as the UN Special Envoy on Tuberculosis. Goosby previously served as the United States Global AIDS Coordinator from 2009 until mid-November 2013. In the role, Goosby directed the U.S. strategy for addressing HIV around the world and led President Obama's implementation of the President's Emergency Plan for AIDS Relief (PEPFAR). Goosby was sworn in during June 2009 and resigned in November 2013, taking a position as a professor at UCSF, where he directs the Center for Global Health Delivery and Diplomacy, a collaboration between UCSF and the University of California, Berkeley.
Stefan Hugo Ernst Kaufmann is a German immunologist and microbiologist and is one of the highly cited immunologists worldwide for the decade 1990 to 2000. He is amongst the 0.01% most cited scientists of c. 7 million scientists in 22 major scientific fields globally.
Sir Alimuddin Zumla,, FRCP, FRCPath, FRSB is a British-Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections, and diseases of poverty. He is known for his leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease. In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division. In 2023, for the sixth consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers. In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences.
There are a number risk factors for tuberculosis infection; worldwide the most important of these is HIV. Co-infection with HIV is a particular problem in Sub-Saharan Africa, due to the high incidence of HIV in these countries. Smoking more than 20 cigarettes a day increases the risk of TB by two to four times while silicosis increases the risk about 30 fold. Diabetes mellitus is also an important risk factor that is growing in importance in developing countries. Other disease states that increase the risk of developing tuberculosis are Hodgkin lymphoma, end-stage renal disease, chronic lung disease, malnutrition, and alcoholism. A person's genetics also play a role.
The United States Intelligence Community (IC) has a long history of producing assessments on infectious diseases. Most of these papers are distributed to government administrators and inform the choices of policymakers. Three of these assessments stand out as analytical products that have had important impact on the awareness, funding and treatment of infectious diseases around the world. The first paper is the National Intelligence Estimate on the Global Infectious Disease Threat, the second paper is the assessment on the Next Wave of HIV/AIDS, and the third paper was the assessment on SARS. This page summarizes the findings of these three papers and provides information about their impact.
Salim S. Abdool Karim, MBChB, MMed, MS(Epi), FFPHM, FFPath (Virol), DipData, PhD, DSc(hc), FRS is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives.
Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as dean of the faculty from 1998 through December 31, 2008.
Céline R. Gounder is an American physician and medical journalist who specializes in infectious diseases and global health. She was a member of the COVID-19 Advisory Board transition team of then-incoming U.S. president Joe Biden. In 2022, she joined the Kaiser Family Foundation as senior fellow and editor-at-large for public health at Kaiser Health News.
Elizabeth Lucy Corbett is a British epidemiologist who is Professor of Tropical Epidemiology at the London School of Hygiene & Tropical Medicine. Her research investigates the regulation of tuberculosis in HIV prevalent populations and improving access to HIV self-testing.
Ibrahim Ibrahim Abubakar is a British-Nigerian epidemiologist who is Professor in Infectious Disease Epidemiology at University College London and Dean of the UCL Faculty of Population Health Sciences.
Tuberculosis elimination is the effort to reduce the number of tuberculosis (TB) cases to less than one per 1 million population, contrasted with the effort to completely eradicate infection in humans worldwide. The goal of tuberculosis elimination is hampered by the lack of rapid testing, short and effective treatment courses, and completely effective vaccine. The WHO as well as the Stop TB Partnership aim for the full elimination of TB by 2050—requiring a 1000-fold reduction in tuberculosis incidence. As of 2017, tuberculosis has not been eliminated from any country.
Ann Marie Kimball is an American physician. She is known for being the pioneer of electronic disease surveillance for infectious disease outbreaks and pandemics. She is currently a Professor Emerita in the Department of Epidemiology at the University of Washington, a Consulting Fellow at the Chatham House Royal Institute of Foreign Affairs, and was a Strategic Consultant in Global Health at the Rockefeller Foundation. Kimball served as a technical and strategic lead for the Bill and Melinda Gates Foundation infectious disease surveillance strategy formation.